2022
DOI: 10.1007/s10787-022-01123-7
|View full text |Cite
|
Sign up to set email alerts
|

Cyclooxygenase-2 activates EGFR–ERK1/2 pathway via PGE2-mediated ADAM-17 signaling in testosterone-induced benign prostatic hyperplasia

Abstract: Objective and design Prostatic inflammation is the driving force in benign prostatic hyperplasia (BPH). This work investigated the potential modulatory effect of COX-2 inhibition on ADAM-17/EGFR/ERK1/2 axis. Materials or subjects Adult male Wistar rats were used. Treatment Celecoxib (10 and 20 mg/kg; i.p.) was injected i.p. daily for three weeks. Testosterone (TST) (3 mg/kg; s.c.) was used to induce BPH. … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
2

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 75 publications
(121 reference statements)
0
1
0
Order By: Relevance
“…TP administration used to build the BPH model in rats was previously proven to generate excessive production of ROS together with attenuation of cellular antioxidant mechanisms [14,42,43]. This could justify the increase in oxidant MDA enzyme and the significantly regressed levels of antioxidant GSH and SOD enzymes in prostatic tissue versus the control group in the current study.…”
Section: Plos Onementioning
confidence: 70%
See 1 more Smart Citation
“…TP administration used to build the BPH model in rats was previously proven to generate excessive production of ROS together with attenuation of cellular antioxidant mechanisms [14,42,43]. This could justify the increase in oxidant MDA enzyme and the significantly regressed levels of antioxidant GSH and SOD enzymes in prostatic tissue versus the control group in the current study.…”
Section: Plos Onementioning
confidence: 70%
“…These cytokines support the expansion of epithelial cells and enlargement of the prostate [12,13]. Certain inflammatory pathways can be activated by oxidative stress via activating transcription factors like NF-кB, which in turn regulate the gene expression of proinflammatory mediators, including TNF-α [14].…”
Section: Introductionmentioning
confidence: 99%
“…The median of the RNA expression was calculated and used as a threshold to differentiate between the higher and lower expression within the factor groups. The mRNA expression was normalized to the expression of the house keeping gene glyceraldehyde 3-phosphate dehydrogenase (GAPDH) 60 , 61 .…”
Section: Methodsmentioning
confidence: 99%